Athos Therapeutics’ decision to go niche with a GPU-as-a-service from upstart Vultr could point the way forward for similar organizations with specialized AI needs.

Anyone keeping a close eye on Amazon (NASDAQ: AMZN) these days certainly already knows the company's fourth-quarter cloud ...